# Management Patterns of Croup in Korean Emergency Departments: A Nationwide Cohort Study

**Authors:** Jin Hee Kim, Jae Yun Jung, Soyun Hwang, Joong Wan Park, Eui Jun Lee, Ha Ni Lee, Do Kyun Kim, Young Ho Kwak

PMC · DOI: 10.3390/children12101301 · 2025-09-25

## TL;DR

In Korean emergency departments, only about half of children with croup received corticosteroids, and specialized pediatric centers used fewer unnecessary treatments compared to general centers.

## Contribution

This study provides a nationwide analysis of croup management patterns and highlights the need for standardized clinical guidelines in Korean emergency departments.

## Key findings

- Only 56.9% of children with croup received corticosteroids in Korean emergency departments.
- Dedicated pediatric emergency centers used fewer low-value interventions like salbutamol and unnecessary radiographs.
- Potentially low-value interventions decreased over time, but corticosteroid use remained stagnant.

## Abstract

What are the main findings?
Despite guideline recommendations, only around half of children with croup in Korean emergency departments received corticosteroids.Dedicated pediatric emergency centers (DPECs) were associated with lower use of potentially low-value interventions (salbutamol and chest and cervical radiography) than general emergency centers (GECs).

Despite guideline recommendations, only around half of children with croup in Korean emergency departments received corticosteroids.

Dedicated pediatric emergency centers (DPECs) were associated with lower use of potentially low-value interventions (salbutamol and chest and cervical radiography) than general emergency centers (GECs).

What is the implication of the main finding?
Education and implementation of standardized national clinical guidelines are needed to optimize croup management in Korean emergency departments.

Education and implementation of standardized national clinical guidelines are needed to optimize croup management in Korean emergency departments.

Background: Despite the established importance of prescribing steroids to children with croup, many physicians in Korean emergency departments (EDs) do not adhere to this recommendation. This study aimed to evaluate treatment appropriateness by investigating steroid prescription rates and potentially low-value interventions such as salbutamol nebulizers and radiographs and to compare dedicated pediatric emergency centers (DPECs) and general emergency centers (GECs) to understand treatment trends for croup in Korea. Methods: This retrospective cohort study analyzed a 5% random sample of the National Health Screening Program for Infants and Children (NHSPIC) cohort linked to the National Health Insurance Service database (2008–2015). The study included children with a primary diagnosis of croup and excluded children who were prescribed oral or steroid injections within three days before their ED visit. The primary outcome was steroid prescription rate; secondary outcomes included comparisons of management patterns between DPECs and GECs. Results: The overall steroid prescription rate was 56.9%. Steroid prescribing was slightly higher in DPECs than in GECs (61.2% vs. 56.3%, p = 0.131). In contrast, DPECs had lower prescription rates for salbutamol nebulizers (4.5% vs. 12.7%, p < 0.001), chest radiographs (65.3% vs. 78.7%, p < 0.001), and cervical spine radiographs (4.5% vs. 12.6%, p < 0.001). Steroid prescription rates showed no significant temporal trend, while potentially low-value interventions decreased significantly. Conclusions: Only about half of children with croup in Korean EDs received steroids. DPECs were associated with lower use of potentially low-value interventions, suggesting more guideline-concordant practice. Education and implementation of standardized national croup clinical guidelines are needed to optimize care.

## Linked entities

- **Chemicals:** salbutamol (PubChem CID 2083)
- **Diseases:** croup (MONDO:0005722)

## Full-text entities

- **Diseases:** Croup (MESH:D003440)
- **Chemicals:** Steroid (MESH:D013256), salbutamol (MESH:D000420)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12562596/full.md

---
Source: https://tomesphere.com/paper/PMC12562596